Dana Farber Cancer Institute at St. Elizabeth's is a clinical research site located in Brighton, Massachusetts, United States 02135.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Dana Farber Cancer Institute at St. Elizabeth's has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.
Sponsors: Dana-Farber Cancer Institute.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Massachusetts · View every site in Brighton
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Dana Farber Cancer Institute at St. Elizabeth's has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Dana Farber Cancer Institute at St. Elizabeth's has 1 clinical trials on record, with 1 currently active. Their work covers Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, Hematological Malignancies.
Dana Farber Cancer Institute at St. Elizabeth's has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.